差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
US 繁體中文
国家 • United States
    实体 • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Citius Pharmaceuticals, Inc. - CTXR CFD

    1.2660
    1.55%
    0.0280
    低: 1.266
    高: 1.3358
    Market Trading Hours* (UTC) Opens on Tuesday at 13:30

    Mon - Fri: 13:30 - 20:00

    • 概括
    • 曆史數據
    • 活動
    • 收入報表
    • 資産負債表
    • 現金流
    • 所有權
    交易條件
    價差 0.0280
    多頭倉位隔夜費用

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜費用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    來自槓桿的資金 ~ $4,000.00
    前往平台
    		-0.025457%
    空頭倉位隔夜費用

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜費用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    來自槓桿的資金 ~ $4,000.00
    前往平台
    		0.003235%
    隔夜費時間 21:00 (UTC)
    最小成交量 1
    貨幣 USD
    保證金 20%
    股票交易 United States of America
    交易委員會 0%

    *Information provided by Capital.com

    Citius Pharmaceuticals Inc ESG Risk Ratings

    High Medium Low Negligible

    “D”分數表示相對 ESG 表現較差，公開報告重要 ESG 數據的透明度不足。

    關鍵數據
    前收盤價* 1.2859
    開盤價* 1.3159
    1 年變化* 41.49%
    日範圍* 1.266 - 1.3358
    52 周範圍 0.77-1.71
    平均交易量（10 天） 1.23M
    平均交易量（3 個月） 30.58M
    市值 209.69M
    市盈率 -100.00K
    流通股 158.86M
    收入 N/A
    EPS -0.21
    股息（收益率 %） N/A
    貝塔 1.39
    下一個財報發布日期 Aug 9, 2023

    所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

    • 上週
    • 上個月
    • 去年
    • 過去兩年
    • 最大
    • 每日
    • 每週
    • 每月
    日期 關閉 更改 變化 (%) 打開 高 低
    Jun 2, 2023 1.2859 0.0398 3.19% 1.2461 1.3059 1.2162
    Jun 1, 2023 1.2361 0.0897 7.82% 1.1464 1.2959 1.1364
    May 31, 2023 1.1364 0.0399 3.64% 1.0965 1.1464 1.0965
    May 30, 2023 1.0965 -0.0100 -0.90% 1.1065 1.1364 1.0965
    May 26, 2023 1.1065 0.0299 2.78% 1.0766 1.1165 1.0766
    May 25, 2023 1.0766 -0.0498 -4.42% 1.1264 1.1264 1.0666
    May 24, 2023 1.1065 0.0200 1.84% 1.0865 1.1364 1.0666
    May 23, 2023 1.0965 -0.0299 -2.65% 1.1264 1.1464 1.0666
    May 22, 2023 1.1264 -0.0399 -3.42% 1.1663 1.1763 1.1264
    May 19, 2023 1.1663 0.0199 1.74% 1.1464 1.1763 1.1264
    May 18, 2023 1.1165 0.0100 0.90% 1.1065 1.1564 1.0866
    May 17, 2023 1.0866 -0.1694 -13.49% 1.2560 1.2561 1.0467
    May 16, 2023 1.2461 0.0000 0.00% 1.2461 1.2660 1.2261
    May 15, 2023 1.2660 -0.1296 -9.29% 1.3956 1.4056 1.2261
    May 12, 2023 1.3956 0.0498 3.70% 1.3458 1.4355 1.2860
    May 11, 2023 1.2959 0.0199 1.56% 1.2760 1.4355 1.2760
    May 10, 2023 1.2461 0.0100 0.81% 1.2361 1.2860 1.1962
    May 9, 2023 1.2261 -0.0399 -3.15% 1.2660 1.2760 1.2261
    May 8, 2023 1.2660 -0.0100 -0.78% 1.2760 1.2959 1.2461
    May 5, 2023 1.2660 0.0000 0.00% 1.2660 1.2959 1.2361

    Citius Pharmaceuticals, Inc. Events

    时间（协调世界时） (UTC) 国家 事件
    Wednesday, August 9, 2023

    时间（协调世界时） (UTC)

    10:59

    国家

    US

    事件

    Q3 2023 Citius Pharmaceuticals Inc Earnings Release
    Q3 2023 Citius Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看完整日曆
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    總收入 0 0 0 0 0
    收入 0 0 0 0 0
    總營業費用 33.3161 23.3653 17.7107 15.5984 13.3391
    銷售/一般/行政費用，總計 15.6606 11.2914 8.89788 7.00146 7.22622
    研究與開發 17.6555 12.2405 8.81281 8.5969 6.56293
    營業收入 -33.3161 -23.3653 -17.7107 -15.5984 -13.3391
    利息收入（費用），非經營淨值 0.2514 0.25099 0.0524 0.03622 -0.01584
    稅前淨收入 -33.0647 -23.0544 -17.5481 -15.5621 -12.5366
    稅後淨收入 -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    未計算非常項目前的淨收益 -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    淨收入 -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    普通股股東可獲收益 (不含非經常性項目) -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    普通股股東可獲收益 (含非經常性項目) -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    攤薄淨收入 -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    攤薄後加權平均股 146.082 108.599 39.1652 20.1618 10.7319
    扣除特別項目的每股攤薄盈利 -0.23029 -0.22565 -0.44805 -0.77186 -1.16817
    每股正常攤薄盈利 -0.23029 -0.22718 -0.44805 -0.77186 -1.2101
    異常費用（收入） 0 -0.16656 0 -0.45
    其他，淨值 0 0.05992 0.11021 0 0.81834
    Total Adjustments to Net Income 0 -1.45088
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    總收入 0 0 0 0 0
    收入 0 0 0 0 0
    總營業費用 10.6853 3.66419 7.54957 8.91665 7.59063
    銷售/一般/行政費用，總計 5.95845 3.80437 3.69234 4.02846 4.13842
    研究與開發 4.72686 3.44552 3.85723 4.88819 3.45221
    營業收入 -10.6853 -3.66419 -7.54957 -8.91665 -7.59063
    利息收入（費用），非經營淨值 0.30328 0.21455 0.13483 0.05302 0.02957
    其他，淨值 0 0
    稅前淨收入 -10.382 -3.44965 -7.41474 -8.86363 -7.56105
    稅後淨收入 -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    未計算非常項目前的淨收益 -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    淨收入 -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    普通股股東可獲收益 (不含非經常性項目) -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    普通股股東可獲收益 (含非經常性項目) -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    攤薄淨收入 -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    攤薄後加權平均股 146.252 146.211 146.146 146.13 146.042
    扣除特別項目的每股攤薄盈利 -0.07197 -0.02458 -0.05468 -0.06066 -0.05177
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常攤薄盈利 -0.07197 -0.04052 -0.05468 -0.06066 -0.05177
    Total Adjustments to Net Income 0 0
    異常費用（收入） 0 -3.58569 0
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流動資産總額 44.5643 72.8143 13.982 7.94192 10.0601
    現金和短期投資 41.7117 70.073 13.8597 7.8938 9.184
    現金等價物 41.7117 70.073 13.8597 7.8938 9.184
    Prepaid Expenses 2.85258 2.7414 0.12224 0.04811 0.05773
    Total Assets 113.999 142.429 43.7737 36.7464 31.0505
    Property/Plant/Equipment, Total - Net 0.65017 0.82985 0.98778 0.00059 0.00148
    Property/Plant/Equipment, Total - Gross
    Accumulated Depreciation, Total
    Goodwill, Net 9.3468 9.3468 9.3468 9.3468 1.5868
    Intangibles, Net 59.4 59.4 19.4 19.4 19.4
    Other Long Term Assets, Total 0.03806 0.03806 0.05709 0.05709 0.00217
    Total Current Liabilities 4.53001 3.98229 4.09713 4.60772 3.18484
    Accounts Payable 1.16538 1.2771 1.85624 2.71354 1.57344
    Accrued Expenses 3.36463 2.7052 2.06793 1.72121 1.43843
    Notes Payable/Short Term Debt 0 0 0.17297 0.17297 0.17297
    Other Current Liabilities, Total 0
    Total Liabilities 11.1734 10.2467 10.103 9.59352 3.18484
    Total Long Term Debt 0 0 0.16458 0 0
    Total Equity 102.826 132.182 33.6707 27.1529 27.8657
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.14621 0.14598 0.05558 0.02893 0.0162
    Additional Paid-In Capital 232.368 228.084 104.209 80.1697 68.1073
    Retained Earnings (Accumulated Deficit) -129.688 -96.0478 -70.5939 -53.0458 -40.2578
    Total Liabilities & Shareholders’ Equity 113.999 142.429 43.7737 36.7464 31.0505
    Total Common Shares Outstanding 146.211 145.979 55.577 28.9305 16.1988
    應收賬款總額，淨額 0.81834
    Long Term Debt 0 0.16458 0
    Deferred Income Tax 5.5618 4.9858 4.9858 4.9858
    Other Liabilities, Total 0.48125 0.67823 0.85547
    Minority Interest 0.60038 0.60038
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流動資産總額 34.9011 42.3174 44.5643 50.8345 58.2593
    現金和短期投資 29.0655 36.8872 41.7117 48.0442 55.7562
    現金等價物 29.0655 36.8872 41.7117 48.0442 55.7562
    Prepaid Expenses 5.8356 5.43013 2.85258 2.79032 2.50311
    Total Assets 104.241 111.705 113.999 120.316 127.786
    Property/Plant/Equipment, Total - Net 0.55484 0.60299 0.65017 0.69642 0.74177
    Goodwill, Net 9.3468 9.3468 9.3468 9.3468 9.3468
    Intangibles, Net 59.4 59.4 59.4 59.4 59.4
    Other Long Term Assets, Total 0.03806 0.03806 0.03806 0.03806 0.03806
    Total Current Liabilities 6.20968 4.53717 4.53001 4.46112 4.02192
    Accounts Payable 2.72559 1.53758 1.16538 1.69052 1.70513
    Accrued Expenses 3.48408 2.99959 3.36463 2.7706 2.3168
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 13.0347 11.2719 11.1734 10.5802 10.1904
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Deferred Income Tax 5.8498 5.7058 5.5618 4.9858 4.9858
    Minority Interest 0.60038 0.60038 0.60038 0.60038 0.60038
    Other Liabilities, Total 0.37483 0.42857 0.48125 0.53288 0.5823
    Total Equity 91.2061 100.433 102.826 109.736 117.596
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.14636 0.14621 0.14621 0.14613 0.14613
    Additional Paid-In Capital 234.868 233.569 232.368 231.287 230.284
    Retained Earnings (Accumulated Deficit) -143.808 -133.282 -129.688 -121.698 -112.834
    Total Liabilities & Shareholders’ Equity 104.241 111.705 113.999 120.316 127.786
    Total Common Shares Outstanding 146.358 146.211 146.211 146.13 146.13
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    淨收入/起跑線 -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    經營活動産生的現金 -28.3613 -24.2504 -16.9307 -12.4377 -11.3181
    經營活動産生的現金 0.00292 0.00149 0.00084 0.00089 0.00175
    非現金物品 4.46091 1.5198 1.48355 0.92758 0.7069
    Cash Taxes Paid
    已付現金利息 0 0.00019
    營運資金的變化 0.23956 -2.71727 -0.86697 2.19592 0.50985
    投資活動産生的現金 0 -40.0069 -0.00183 0 0
    其他投資現金流量項目，總計 0
    融資活動産生的現金 0 120.471 22.8984 11.1475 17.298
    融資現金流項目 0 18.4504 0 0
    債務的發行（退還），淨額 0 -0.17297 0.16458 0 0
    現金淨變化 -28.3613 56.2132 5.96594 -1.2902 5.9799
    資本支出 0 -40.0069 -0.00183 0 0
    股票的發行（報廢），淨額 0 102.193 22.7339 11.1475 17.298
    Deferred Taxes 0.576
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -14.1197 -3.59365 -33.6407 -25.6499 -16.7863
    Cash From Operating Activities -12.6774 -4.82444 -28.3613 -22.0287 -14.3167
    Cash From Operating Activities 0.00146 0.00073 0.00292 0.00219 0.00146
    Non-Cash Items 2.56255 1.24754 4.46091 3.3344 2.28611
    Changes in Working Capital -1.40977 -2.62306 0.23956 0.28456 0.18199
    Cash From Financing Activities 0.03127 0 0 0 0
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 0.03127 0 0 0
    Issuance (Retirement) of Debt, Net 0 0 0
    Net Change in Cash -12.6462 -4.82444 -28.3613 -22.0287 -14.3167
    Cash From Investing Activities 0 0 0
    Capital Expenditures 0 0
    Deferred Taxes 0.288 0.144 0.576
    Other Investing Cash Flow Items, Total 0
    投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
    Mazur (Leonard L) Individual Investor 6.4557 10255342 -1 2022-11-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.8112 6054328 40301 2023-03-31 LOW
    Armistice Capital LLC Hedge Fund 1.5265 2425000 -3743361 2021-12-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4586 2317168 4868 2023-03-31 LOW
    Holubiak (Myron Z) Individual Investor 1.2541 1992243 0 2022-11-30
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8428 1338777 6154 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3 476597 34000 2023-03-31 LOW
    Susquehanna International Group, LLP Investment Advisor 0.2893 459511 130223 2023-03-31 MED
    GSA Capital Partners LLP Hedge Fund 0.2849 452561 -46222 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.2513 399270 -9900 2023-03-31 HIGH
    Millennium Management LLC Hedge Fund 0.1917 304482 -246644 2023-03-31 HIGH
    Jane Street Capital, L.L.C. Research Firm 0.1549 246023 224990 2023-03-31 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1541 244755 7008 2023-03-31 LOW
    Hightower Advisors, LLC Investment Advisor 0.1317 209198 14713 2023-03-31 LOW
    Inspire Advisors, LLC Investment Advisor 0.125 198632 2686 2023-03-31 LOW
    Wealth Advisory Solutions, L.L.C. Investment Advisor 0.0981 155850 0 2023-03-31 MED
    AHL Partners LLP Investment Advisor 0.0836 132826 86615 2023-03-31 HIGH
    Morgan Stanley & Co. LLC Research Firm 0.0759 120521 31943 2023-03-31 MED
    Qube Research & Technologies Ltd Hedge Fund 0.063 100106 -20474 2023-03-31 HIGH
    Kestra Advisory Services, LLC Investment Advisor 0.0579 91917 -1800 2023-03-31 MED

    為什麼選擇Capital.com？我們用表現來證明自己。

    Capital.com Group

    535K+

    貿易商

    87K+

    每月活躍客戶

    $113M+

    每月投資額

    $64M+

    每月提取

    差價合約交易計算器

    如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

    交易佣金
    0
    • 1:1
    槓桿
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投資
    交易規模（槓桿 x 投資）：
    打開

    關閉

    做空 做多
    過往表現並非未來業績的可靠指標
    盈利/虧損
    Industry: Biotechnology & Medical Research (NEC)

    11 Commerce Dr Fl 1
    CRANFORD
    NEW JERSEY 07016-3501
    US

    收入報表

    • Annual
    • Quarterly

    人們也觀看

    Gold

    1,961.31 Price
    +0.670% 1D Chg, %
    多頭倉位隔夜費用 -0.0184%
    空頭倉位隔夜費用 0.0102%
    隔夜費時間 21:00 (UTC)
    價差 0.30

    Oil - Crude

    71.94 Price
    -0.040% 1D Chg, %
    多頭倉位隔夜費用 -0.0149%
    空頭倉位隔夜費用 -0.0070%
    隔夜費時間 21:00 (UTC)
    價差 0.03

    XRP/USD

    0.51 Price
    -7.390% 1D Chg, %
    多頭倉位隔夜費用 -0.0753%
    空頭倉位隔夜費用 0.0069%
    隔夜費時間 21:00 (UTC)
    價差 0.00400

    BTC/USD

    25,774.85 Price
    -5.490% 1D Chg, %
    多頭倉位隔夜費用 -0.0616%
    空頭倉位隔夜費用 0.0137%
    隔夜費時間 21:00 (UTC)
    價差 60.00

    還在尋找值得信賴的經紀商？

    加入全球 535.000 多名交易者，選擇與 Capital.com 交易

    1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易